Neuronetics Inc (STIM) — 13F Holders Deep Dive (Q2 2026)

STIM ranks #4873 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

STIM is a top-conviction position for Madryn Asset Management, LP — at 65.3% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

Wexford Capital LP has added to its STIM position for two straight quarters, increasing it by $1.7M to reach $2.6M today.

Fidelity has trimmed its STIM position for two straight quarters, cutting it by $101.4K while still holding $6.6K.

STIM reported a net loss of $30.4M over the trailing twelve months.

• Not yet profitable — net loss of $30.4M over the trailing twelve months
• Revenue grew 39.6% year over year
• Net income improved year over year, from -$48.8M to -$30.4M
• Operating cash flow was negative, using $20.4M in cash
• Current ratio of 2.02x — enough short-term assets to cover short-term liabilities
• Liabilities run 5.15x equity — a highly leveraged balance sheet worth noting